Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore what the best retirement strategy entails. Equip yourself with knowledge to secure a comfortable and financially stable future.
19,724 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Archer Aviation’s stock rally fizzled as the market shifted away from high-growth bets with unproven models. This art...
February data show a 9% month-over-month rise in rate-lock volume as lower borrowing costs draw buyers back. Purchase...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
New data shows a broad wave of exits ahead as U.S. founders prepare to monetize stakes. The multi-year shift could re...
Cogent is moving from fading legacy lines to wavelength services for AI infrastructure, yet its stock remains under p...
Nvidia has committed $2 billion to Nebius Group, accelerating Nebius’s role in the neocloud era. The move includes ea...
A coalition of rap legends led by Travis Scott takes a bold legal stand at the Supreme Court. This isn’t just a court...
Major restaurant chains are testing smaller portions as inflation and weight-management trends push diners toward val...
As cyber threats rise, sentinelOne's 2026 earnings call will reveal how the company plans to expand its AI-driven pla...
Ulta Beauty beat earnings and revenue expectations in the latest quarter, but investors focused on margin pressure an...